CHEMICAL-MODELS OF EPILEPSY WITH SOME REFERENCE TO THEIR APPLICABILITY IN THE DEVELOPMENT OF ANTICONVULSANTS

被引:123
作者
DEDEYN, PP [1 ]
DHOOGE, R [1 ]
MARESCAU, B [1 ]
PEI, YQ [1 ]
机构
[1] ACAD ZIEKENHUIS MIDDELHEIM, DEPT NEUROL, ANTWERP, BELGIUM
关键词
EPILEPSY; CHEMICAL MODEL; CONVULSANT; ANTICONVULSANT; DRUG SCREENING;
D O I
10.1016/0920-1211(92)90030-W
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This paper reviews chemical models of epilepsy and their relevance in the identification and characterization of anticonvulsants. For each convulsant we discuss possible modes of administration, clinical type(s) of seizures induced, proposed mechanism(s) of epileptogenesis and, where available, responsiveness of the induced seizures to anticonvulsants. The following compounds are reviewed: pentylenetetrazol, bicuculline, penicillin, picrotoxin, beta-carbolines, 3-mercaptopropionic acid. hydrazides, allylglycine, the glycine antagonist strychnine: gamma-hydroxybutyrate; excitatory amino acids (glutamate, aspartate, N-methyl-D-aspartate, quisqualate, kainate, quinolinic acid); monosubstituted guanidino compounds, metals (alumina, cobalt, zinc, iron) neuropeptides (opioid peptides, corticotropin releasing factor, somatostatin, vasopressin); cholinergic agents (acetylcholine. acetylcholinesterase inhibitors, pilocarpine); tetanus toxin; flurothyl, folates; homocysteine and colchicine. Although there are a multitude of chemical models of epilepsy, only a limited number are applied in the routine screening of potential anticonvulsants. Some chemical models have a predictive value with regard to the clinical profile of efficacy of the tested anticonvulsants. Some chemical models may contribute to a better understanding of possible mechanisms of epileptogenesis.
引用
收藏
页码:87 / 110
页数:24
相关论文
共 245 条
  • [101] KASTING NW, 1983, EXPERIENTIA, V37, P1001
  • [102] CHANGES OF IMMUNOREACTIVE SOMATOSTATIN AND BETA-ENDORPHIN CONTENT IN RAT-BRAIN AFTER AMYGDALOID KINDLING
    KATO, N
    HIGUCHI, T
    FRIESEN, HG
    WADA, JA
    [J]. LIFE SCIENCES, 1983, 32 (21) : 2415 - 2422
  • [103] KENT AP, 1983, BRIT J PHARMACOL, V78, P553, DOI 10.1111/j.1476-5381.1983.tb08815.x
  • [104] EFFECT ON CEREBRAL D-[H-3] ASPARTATE RELEASE OF 3-MERCAPTOPROPIONIC ACID AND METHYL-6,7-DIMETHOXY-4-ETHYL-BETA-CARBOLINE-3-CARBOXYLATE
    KERWIN, RW
    MELDRUM, BS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 89 (3-4) : 265 - 269
  • [105] SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN THE CEREBROSPINAL-FLUID OF NEUROLOGICAL PATIENTS
    KOHLER, J
    SCHROTER, E
    CRAMER, H
    [J]. ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1982, 231 (06): : 503 - 508
  • [106] Recurrent convulsive seizures in animals produced by immunologic and chemical means
    Kopeloff, LM
    Barrera, SE
    Kopeloff, N
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1942, 98 (06) : 881 - 902
  • [107] KOPELOFF LM, 1960, P SOC EXP BIOL MED, V104, P500
  • [108] CHRONIC EXPERIMENTAL EPILEPSY IN MACACA MULATTA
    KOPELOFF, LM
    CHUSID, JG
    KOPELOFF, N
    [J]. NEUROLOGY, 1954, 4 (03) : 218 - 227
  • [109] THE EPILEPTOGENIC EFFECT OF SUBCORTICAL ALUMINA CREAM IN THE RHESUS MONKEY
    KOPELOFF, N
    WHITTIER, JR
    PACELLA, BL
    KOPELOFF, LM
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1950, 2 (02): : 163 - 168
  • [110] KRALL RL, 1978, EPILEPSIA, V19, P404